首页> 外文期刊>Annals of surgical oncology >Nodal staging in adenocarcinoma of the gastro-esophageal junction. Proposal of a specific staging system.
【24h】

Nodal staging in adenocarcinoma of the gastro-esophageal junction. Proposal of a specific staging system.

机译:胃食管交界处腺癌的淋巴结分期。特定分期系统的建议。

获取原文
获取原文并翻译 | 示例
       

摘要

PURPOSE: This study was aimed at developing a proper nodal staging system for GEJ adenocarcinoma. METHODS: The study analyzed 113 patients with GEJ adenocarcinoma consecutively resected at the Department of General Surgery and Surgical Oncology of the University of Siena and at the Department of General Surgery of the University of Verona. Both the number (TNM) and site (JGCA) of lymph node metastasis was evaluated in considering nodal staging. RESULTS: The TNM and JGCA staging systems coincided only in 56.3% of cases. Nodal involvement resulted to be the most important prognostic factor considering both the staging systems (P < 0.001). An extremely poor prognosis and a prominent risk of death were observed for patients with more than six metastatic nodes (TNM pN2-3) as well as for patients with involvement of second and third tier nodes (JGCA pN2-3) (P < 0.001). The combined prognostic significance of the two classifications showed a similar risk of death for patients with less than seven metastatic nodes (TNM pN1) located beyond the first tier (JGCA pN2-3) and for patients with more than six involved nodes (TNM pN2-3) independently from the interested level (JGCA pN1-3). Accordingly, these classes were pooled together and four classes considered: pN0, TNM-JGCA pN1, TNM pN2-3 or JGCA pN2-3, M1a (P < 0.001). CONCLUSIONS: The combination of the TNM and JGCA staging systems herein proposed is extremely practical from a clinical point of view and leads to the stratification of pN+ patients in two classes only with very different risk of death.
机译:目的:本研究旨在为GEJ腺癌开发合适的淋巴结分期系统。方法:该研究分析了在锡耶纳大学普通外科和肿瘤外科以及维罗纳大学普通外科连续切除的113例GEJ腺癌患者。淋巴结转移的数目(TNM)和部位(JGCA)均在考虑淋巴结分期时进行了评估。结果:TNM和JGCA分期系统仅在56.3%的病例中重合。考虑到两个分期系统,淋巴结转移是最重要的预后因素(P <0.001)。转移淋巴结多于六个的患者(TNM pN2-3)以及第二和第三层淋巴结受累的患者(JGCA pN2-3)的预后极差,并且死亡风险显着(P <0.001) 。两种分类的合并预后意义显示,对于位于第一层以外的转移结节(TNM pN1)少于七个的患者(JGCA pN2-3)和受累结点多于六个的患者(TNM pN2-),存在相似的死亡风险3)独立于感兴趣级别(JGCA pN1-3)。因此,将这些类别合并在一起,并考虑了四个类别:pN0,TNM-JGCA pN1,TNM pN2-3或JGCA pN2-3,M1a(P <0.001)。结论:从临床角度来看,本文提出的TNM和JGCA分期系统的组合非常实用,可导致pN +患者分为两类,仅具有非常不同的死亡风险。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号